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he PEX11 peroxisomal membrane proteins are the
only factors known to promote peroxisome division
in multiple species. It has been proposed that PEX11
proteins have a direct role in peroxisomal fatty acid oxidation,
and that they only affect peroxisome abundance indirectly.
Here we show that PEX11 proteins are unique in their
ability to promote peroxisome division, and that PEX11
overexpression promotes peroxisome division in the absence
of peroxisomal metabolic activity. We also observed that
T
 
mouse cells lacking 
 
PEX11
 
 
 
 display reduced peroxisome
abundance, even in the absence of peroxisomal metabolic
 
substrates, and that 
 
PEX11
 
 
 
 
 
/
 
 
 
 mice are partially deﬁcient
in two distinct peroxisomal metabolic pathways, ether lipid
synthesis and very long chain fatty acid oxidation. Based
on these and other observations, we propose that PEX11
proteins act directly in peroxisome division, and that their
loss has indirect effects on peroxisome metabolism.
 
Introduction
 
Peroxisomes are single membrane-bound organelles that
import all of their protein and most of their lipid content
(Lazarow and Fujiki, 1985). In most species, peroxisomes
contribute to an array of lipid metabolic pathways, includ-
ing the 
 
 
 
-oxidation of fatty acids (Wanders and Tager,
1998; Tabak et al., 1999). The importance of peroxisomal
function in human development is underscored by the lethal
diseases caused by defects in peroxisome function, including
generalized defects in peroxisome biogenesis (Gould et al.,
2001; Wanders et al., 2001a). The biogenesis of peroxisomal
proteins involves their synthesis on cytosolic polyribosomes
and their posttranslational import into the peroxisome
matrix and membrane (Lazarow and Fujiki, 1985). The
existence of this direct cytoplasm-to-peroxisome protein
import pathway led to the proposal that peroxisomes grow
by uptake of protein and lipid content, followed by their
division to yield nascent peroxisomes (Lazarow and Fujiki,
1985). Although this model cannot explain all aspects of
peroxisome biogenesis (Gould and Valle, 2000; Sacksteder
and Gould, 2000), a large body of evidence suggests that
peroxisomes can arise by peroxisome growth and division
(Purdue and Lazarow, 2001).
Peroxisome division is poorly understood. We previously
established that defects in peroxisomal fatty acid 
 
 
 
-oxidation
reduce peroxisome abundance in mammalian cells, indicat-
ing that there may be metabolic control of peroxisome divi-
sion (Chang et al., 1999). PEX11 proteins have also been
implicated in the regulation of peroxisome abundance.
Studies in yeast demonstrated that loss of 
 
PEX11
 
 caused a
signification reduction in peroxisome abundance and that
 
PEX11
 
 overexpression caused a pronounced increase in their
abundance (Erdmann and Blobel, 1995; Marshall et al.,
1995; Sakai et al., 1995). A similar ability to promote perox-
isome proliferation was also reported for human (Abe and
Fujiki, 1998; Abe et al., 1998; Schrader et al., 1998), rodent
(Passreiter et al., 1998; Schrader et al., 1998), and protozoan
(Lorenz et al., 1998; Maier et al., 2001) forms of 
 
PEX11
 
.
These results have previously been interpreted to support a
direct role for PEX11 in peroxisome division (Gould and
Valle, 2000). However, recent studies have demonstrated
that loss of yeast 
 
PEX11
 
 blocks the peroxisomal oxidation of
medium chain fatty acids (MCFAs)* and that other defects
in MCFA oxidation reduce peroxisome abundance (van
Roermund et al., 2000, 2001). In fact, van Roermund et al.
(2000) proposed that the role of 
 
PEX11
 
 in peroxisome divi-
sion is a secondary, indirect consequence of its role in
MCFA oxidation. Furthermore, they suggested that flux of
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MCFAs through the peroxisomal 
 
 
 
-oxidation pathway gener-
ates a signaling molecule that promotes peroxisome division.
We tested this hypothesis of PEX11 function in mamma-
lian cells and yeast. We demonstrated that PEX11 proteins
are able to drive peroxisome division in the absence of per-
oxisome metabolism, and that the loss of murine PEX11
 
 
 
causes a reduction in peroxisome abundance in the absence
of peroxisomal metabolic substrates. These results, together
with the fact that the loss of PEX11 proteins affects multi-
ple, unrelated peroxisomal metabolic activities, suggest a re-
vised model of PEX11 function. We propose that PEX11
proteins play a direct role in peroxisome division and that
their loss inhibits peroxisome metabolism indirectly, perhaps
due to altered membrane structure or dynamics.
 
Results
 
The peroxisome-proliferating activity 
of human PEX11
 
 
 
Humans express at least two forms of PEX11, PEX11
 
 
 
 and
PEX11
 
 
 
, both of which behave as integral peroxisomal
membrane proteins (PMPs) (Abe and Fujiki, 1998; Abe et
al., 1998; Schrader et al., 1998). We previously reported
that overexpression of human PEX11
 
 
 
 induces a pro-
nounced increase in peroxisome abundance (Schrader et al.,
1998). This process involves at least three kinetically distinct
steps, as determined by immunofluorescence microscopy ex-
periments in normal human fibroblasts. Within 1.5–2 h af-
ter microinjection of pcDNA3-
 
PEX11
 
 
 
myc
 
, PEX11
 
 
 
myc is
detected in peroxisomes of normal abundance and morphol-
ogy (Fig. 1, A and B). By 4–8 h after DNA injection, the
peroxisomes in PEX11
 
 
 
myc-expressing cells begin to elon-
gate (Fig. 1, C and D). This is followed by a large increase in
peroxisome abundance by 24–48 h after transfection (Fig. 1,
E and F).
To determine the specificity and extent of PEX11
 
 
 
-
induced peroxisome division we measured peroxisome
abundance in human cells expressing PEX11
 
 
 
myc in cells
expressing another unrelated PMP, PMP34myc, and in un-
transfected cells. PMP34 is the human homologue (Wylin et
al., 1999) of the 
 
Saccharomyces cerevisiae
 
 peroxisomal adenine
nucleotide carrier (Palmieri et al., 2001; van Roermund et
al., 2001), another yeast protein required for MCFA 
 
 
 
-oxi-
dation. Normal human fibroblasts were transfected with the
PMP34myc or PEX11
 
 
 
myc expression vectors, grown for
2 d, and then processed for indirect immunofluorescence us-
ing antibodies specific for the c-myc epitope tag as well as
with antibodies specific for an endogenously expressed PMP,
PEX14 (Fransen et al., 1998; Shimizu et al., 1999; Will et
al., 1999). Transfected and untransfected control cells were
then examined by confocal fluorescence microscopy, and
peroxisome abundance was determined by counting the
number of distinct peroxisomal profiles in the widest region
of the cell, in 0.5-
 
 
 
m thick sections (Fig. 2). Peroxisome
abundance in untransfected human fibroblasts was 94 
 
 
 
 36
peroxisomes per section (pps). Cells expressing PMP34myc
had virtually the same numbers of peroxisomes (101 
 
 
 
 37
pps). In contrast, cells expressing PEX11
 
 
 
myc had 964 
 
 
 
341 pps, an increase of 1,000%. We also examined peroxi-
some abundance in cells overexpressing COOH-terminally
myc-tagged forms of human PEX3 (Kammerer et al., 1998),
PEX10 (Warren et al., 1998), PEX12 (Chang et al., 1997),
PEX13 (Bjorkman et al., 1998), PMP22 (unpublished data),
PMP24 (Reguenga et al., 1999), PMP70 (Gärtner and Valle,
1993), ALDP (Mosser et al., 1993), P70R (Shani et al.,
1997), and ALDR (Lombard-Platet et al., 1996). As with
PMP34, their overexpression also had no effect on peroxi-
some abundance (unpublished data). These results reveal
that the increase in peroxisome abundance induced by
PEX11
 
 
 
 expression reflects a specific activity of PEX11
 
 
 
and is not a general consequence of PMP overexpression.
 
The peroxisome-proliferating activity of human 
PEX11
 
 
 
 is independent of peroxisome metabolism
 
In a prior report, van Roermund et al. (2000) hypothesized
that PEX11 proteins play direct roles in MCFA oxidation,
and that their ability to affect peroxisome division is an indi-
rect effect of their role in peroxisome metabolism. This hy-
pothesis predicts that a functional peroxisomal 
 
 
 
-oxidation
pathway is an essential prerequisite if PEX11 is to have any
effect on peroxisome abundance. A simple way to test this
hypothesis is to determine whether PEX11-mediated peroxi-
some division occurs in cells that lack a functional peroxiso-
mal 
 
 
 
-oxidation pathway. Although human fibroblasts with
severe defects in isolated peroxisomal 
 
 
 
-oxidation enzymes
are known (Poll-The et al., 1988; van Grunsven et al., 1998;
Chang et al., 1999), human cells contain at least two distinct
sets of peroxisomal 
 
 
 
-oxidation enzymes (Wanders and
Tager, 1998; Wanders et al., 2001a). Therefore, a valid test
of this hypothesis in human cells can only be performed in
Figure 1.  PEX11 -mediated peroxisomal proliferation is a multistep 
process. Wild-type human skin fibroblasts GM5756 were micro-
injected with pcDNA3-PEX11 myc and processed at 1.5 h (A and 
B), 4.5 h (C and D) and 48 h (E and F) after injection for double 
indirect immunofluorescence with antibodies to the myc epitope 
(A, C, and E) and PEX14 (B, D, and F). Note that elongated peroxi-
somes appear 4.5 h after microinjection. Bar, 20  m. 
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cells that lack all peroxisomal metabolic functions but still
contain peroxisomes. Most Zellweger syndrome cell lines
have precisely this phenotype, including the 
 
PEX5
 
-deficient
cell line PBD005 (Dodt et al., 1995). PBD005 cells are ho-
mozygous for an inactivating mutation in the 
 
PEX5
 
 gene
(R390X), lack detectable 
 
PEX5
 
 mRNA, fail to import any
PTS1 or PTS2 proteins into peroxisomes, and are defective
in multiple peroxisomal metabolic activities, including per-
oxisomal fatty acid 
 
 
 
-oxidation and peroxisomal ether lipid
synthesis (Dodt et al., 1995).
PBD005 cells were transfected with either pcDNA3-
 
PEX11
 
 
 
myc
 
 or pcDNA3-
 
PMP34myc
 
, incubated for 2 d,
processed for indirect immunofluorescence, and observed
by confocal immunofluorescence microscopy. Peroxisome
abundance was thirty times higher in PBD005 cells overex-
pressing PEX11
 
 
 
myc (979 
 
 
 
 388 pps) as compared with
untransfected cells (32 
 
 
 
 16 pps), and was unaffected by
overexpression of PMP34myc (35 
 
 
 
 15 pps) (Fig. 3). Thus,
the peroxisome-proliferating activity of human PEX11
 
 
 
 is
not dependent on peroxisomal 
 
 
 
-oxidation activities. Fur-
thermore, because PBD005 cells are defective in all known
peroxisomal metabolic activities and are unable to import
peroxisomal matrix enzymes (Dodt et al., 1995), we can
conclude that the peroxisome-proliferating activity of hu-
man PEX11
 
 
 
 is independent of all peroxisomal metabolic
activities. In a previous study (Chang et al., 1999), we re-
ported that defects in peroxisomal 
 
 
 
-oxidation, due to either
(a) isolated defects in the acyl-CoA oxidase 1 (Poll-The et
al., 1988) or the D-bifunctional protein (D-BP) (van
Grunsven et al., 1998) genes, or (b) defects in genes that are
required for peroxisomal matrix protein import (e.g., 
 
PEX5
 
)
(Dodt et al., 1995), cause a significant reduction in peroxi-
some abundance. Thus, it was expected that peroxisome
abundance would be reduced in untransfected PBD005 cells
Figure 2.  Overexpression of PEX11  increases peroxisome 
abundance in wild-type human skin fibroblasts. (A) Peroxisome 
abundance in GM5756 cells, GM5756 cells overexpressing 
PMP34myc, and GM5756 cells overexpressing PEX11 myc. (B–E) 
Representative cells transfected with pcDNA3-PMP34myc (B and C) 
and pcDNA3-PEX11 myc (D and E). GM5756 cells were transfected 
with pcDNA3-PEX11 myc or pcDNA3-PMP34myc. 2 d after 
transfection, cells were processed for indirect immunofluorescence 
with antibodies to the myc epitope (B and D) and PEX14 (C and E). 
Samples were examined under a confocal fluorescence microscope 
and the number of peroxisomes present in at least 30 randomly 
selected cells was counted. Results in A are presented as the average 
peroxisome abundance   one standard deviation. Bar, 20  m.
Figure 3.  Overexpression of PEX11  increases peroxisome 
abundance in PEX5-deficient cell line PBD005. (A) Peroxisome 
abundance in PBD005 cells, PBD005 cells overexpressing 
PMP34myc, and PBD005 cells overexpressing PEX11 myc. (B–E) 
Representative cells transfected with pcDNA3-PMP34myc (B and C) 
and pcDNA3-PEX11 myc (D and E). PBD005 cells were transfected 
with pcDNA3-PEX11 myc or pcDNA3-PMP34myc. 2 d after 
transfection, the cells were processed for indirect immunofluores-
cence with antibodies to the myc epitope (B and D) and PEX14 
(C and E). Samples were examined under a confocal fluorescence 
microscope and the number of peroxisomes present in at least 30 
randomly selected cells was counted. Results in A are presented as the 
average peroxisome abundance   one standard deviation. Bar, 20  m. 
646 The Journal of Cell Biology 
 
|
 
 
 
Volume 156, Number 4, 2002
 
(32 
 
 
 
 16 pps) as compared with untransfected normal hu-
man fibroblasts (94 
 
  
 
36 pps) (Fig. 3).
 
Fatty acid 
 
 
 
-oxidation is not required for
PEX11-mediated peroxisome proliferation in yeast
 
Next, we tested whether yeast Pex11p can induce peroxi-
some division in the absence of metabolite flux through
the peroxisomal 
 
 
 
-oxidation pathway. To determine the
range of peroxisome abundance in our 
 
S. cerevisiae
 
 labora-
tory strain (BY4733) (Baker-Brachmann et al., 1998), we
transformed this strain with a plasmid designed to consti-
tutively express GFP/PTS1 (p
 
PGK1
 
-GFP/PTS1), a form
of green fluorescent protein that is imported into the per-
oxisome lumen (Kalish et al., 1996), and measured the
number of GFP/PTS1-containing peroxisomes in BY4733
cells grown in either glucose or oleic acid medium (120
cells counted per strain). Peroxisomes are the sole site of
fatty acid 
 
 
 
-oxidation in 
 
S. cerevisiae
 
, and numerous stud-
ies have demonstrated that peroxisome abundance in-
creases when 
 
S. cerevisiae
 
 cells are shifted from glucose-
dependent growth to growth on fatty acids such as oleic
acid (Erdmann et al., 1989; Kunau et al., 1993; Erdmann
and Blobel, 1995; Marshall et al., 1995). As expected, per-
oxisome abundance was higher in the oleate-grown cells
than in glucose-grown cells (Fig. 4, A and B). The pro-
nounced variability in peroxisome abundance we detected
under both growth conditions was unexpected, given the
relatively uniform numbers of peroxisomes reported previ-
ously for the 
 
S. cerevisiae
 
 strain BJ1991 (van Roermund et
al., 2000). One difference between the strains BY4733
and BJ1991 is that BY4733 cells are competent for perox-
isome degradation by pexophagy, whereas the 
 
pep4
 
 allele
of BJ1991 cells should render that strain resistant to pex-
ophagy and result in longer peroxisome half-lives (Kim
and Klionsky, 2000).
With the range of peroxisome abundance established by
comparing glucose- and oleate-grown BY4733 cells, we
next examined the effect of 
 
PEX11
 
 expression on peroxi-
some abundance in cells that are grown in media that is de-
void of fatty acids. We deleted the chromosomal copy of
the 
 
PEX11
 
 gene from BY4733 and then introduced
p
 
PGK1
 
-GFP/PTS1 to generate the strain XLY1. XLY1
cells were further modified by the addition of a high copy,
 
GAL1
 
 promoter–containing plasmid (pRS425/
 
GAL1
 
) and
derivatives of this plasmid that are designed to express
Ypr128Cp, the adenine nucleotide carrier of the peroxi-
some membrane (Palmieri et al., 2001; van Roermund et
al., 2001) (pRS425/
 
GAL1
 
-
 
YPR128C
 
), Pex13p, a PMP in-
volved in peroxisomal matrix protein import (Elgersma et
al., 1996; Erdmann and Blobel, 1996; Gould et al., 1996)
(pRS425/
 
GAL1
 
-
 
PEX13
 
), and Pex11p (pRS425/
 
GAL1
 
-
 
PEX11
 
). These strains were grown for 17 h in minimal me-
dium lacking fatty acids (S medium) and containing either
2% glucose or 1% galactose as the sole carbon source. The
cells were then fixed and the numbers of peroxisomes in
120 cells from each population were determined by fluores-
cence microscopic examination of the samples.
Peroxisome abundance increased merely by releasing cells
from glucose repression (Fig. 4, C and D). This is not sur-
prising given the role of 
 
ADR1
 
 in glucose repression and the
Figure 4.  Overexpression of PEX11 in S. cerevisiae increases 
peroxisome abundance in lipid-free medium. Various S. cerevisiae 
strains were cultured by different conditions and the peroxisome 
number was counted under fluorescence microscopy in 120 cells for 
each sample. Figures shown here are the frequency distribution of cells 
with different peroxisome number. (A and B) BY4733 cells transformed 
with pPGK1-GFP/PTS1 and pRS425/GAL1 were precultured in S mini-
mal medium with 2% glucose to midlog phase (A), shifted to minimal 
medium containing 0.2% oleic acid and 0.02% Tween 40, cultured for 
17 h (B). (C and D) XLY1 cells carrying pRS425/GAL1 were precultured 
in minimal S medium with 2% glucose to midlog phase (C), shifted to 
minimal medium containing 1% galactose and cultured for 17 h (B). 
(E–G) Galactose induced XLY1 cells transformed with pRS425/
GAL1-PEX13 (E), pRS425/GAL1-YPR128C (F), and pRS425/GAL1-
PEX11 (G). (H and I) Galactose induced XYL2 cells transformed with 
pRS425/GAL1-PEX13 (H) and pRS425/GAL1-PEX11 (I). Note that 
profile shifts in XYL1 and XYL2 cells overexpressing PEX11 were 
comparable to that of oleic acid induced wild-type cells. 
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fact that 
 
ADR1
 
 regulates the expression of many peroxisomal
protein-encoding genes (Gurvitz et al., 2000; Ramil et al.,
2000). Galactose-induced expression of 
 
PEX13
 
 (Fig. 4 E) or
 
YPR128C
 
 (Fig. 4 F) failed to increase peroxisome abundance
beyond what was observed in galactose-grown XLY1 cells
carrying the empty vector (Fig. 4 D), indicating that overex-
pression of PMPs alone is not sufficient to increase peroxi-
some abundance. In contrast, galactose-induced expression
of 
 
PEX11
 
 increased peroxisome abundance to levels that
were observed in oleate-grown BY4733 cells (Fig. 4 G). The
absence of fatty acids from the growth media (S-Gal) makes
it extremely unlikely that there was any significant flux of
substrates through the peroxisomal fatty acid 
 
 
 
-oxidation
pathway in these experiments. Thus, our results suggest that
 
S. cerevisiae
 
 Pex11p has intrinsic peroxisome-proliferating ac-
tivity. As an alternative test of this hypothesis, we repeated
these experiments in XLY2 cells, a 
 
pox1
 
 derivative of XLY1.
 
POX1
 
 encodes the peroxisomal acyl-CoA oxidase, which cat-
alyzes the first committed step in fatty acid 
 
 
 
-oxidation and
is essential for 
 
 
 
-oxidation of all fatty acids in 
 
S. cerevisiae
 
(Wang et al., 1994). Galactose-induced expression of 
 
PEX13
 
had no effect on peroxisome abundance in XLY2 cells (Fig. 4
H). In contrast, galactose-induced expression of PEX11 in
XLY2 cells increased peroxisome abundance to levels that
were similar to PEX11-expressing XLY1 cells and oleate-
grown BY4733 cells (Fig. 4 I).
 
Loss of mouse PEX11
 
 
 
 has an indirect effect on 
peroxisome metabolism
 
The ability of human and yeast PEX11 proteins to promote
peroxisome division independent of peroxisomal fatty acid
 
 
 
-oxidation, combined with the fact that loss of yeast
PEX11 reduces peroxisomal MCFA oxidation, suggests two
possible models of PEX11 function: either PEX11 proteins
have multiple, independent functions in both peroxisome
division and MCFA oxidation, or the effect of PEX11 defi-
ciency on peroxisome metabolism is indirect. We recently
generated mice lacking the 
 
PEX11
 
 
 
 gene (unpublished
data). If PEX11
 
 
 
 functions primarily in fatty acid oxidation,
then peroxisome abundance should be the same in
 
PEX11
 
 
 
 
 
/
 
 
 
 and 
 
PEX11
 
 
 
 
 
/
 
 
 
 cells when these two cell lines
are grown in serum-free medium, which is devoid of lipids
and lacks substrates of the peroxisomal fatty acid oxidation
pathway. However, if PEX11
 
 
 
 functions primarily in perox-
isome division, peroxisome abundance should be reduced in
 
PEX11
 
 
 
 
 
/
 
 
 
 cells relative to 
 
PEX11
 
 
 
 
 
/
 
 
 
 cells.
Mouse embryonic fibroblasts from 
 
PEX11
 
 
 
 
 
/
 
 
 
 and
 
PEX11
 
 
 
 
 
/
 
 
 
 mice were generated. After a 24-h incubation
in serum-free medium, the cells were fixed, permeabilized,
and processed for immunofluorescence using antibodies
specific for the peroxisomal enzyme catalase and the PMP
PEX14 (Fig. 5). Peroxisome abundance was quantified by
counting the number of peroxisomes per section in 60
cells. For 
 
PEX11
 
 
 
 
 
/
 
  cells grown under these conditions,
we detected an average peroxisome abundance of 230  
52 pps. Peroxisome abundance in PEX11 
 /  cells grown
under identical conditions was approximately half of that
wild-type cells, 128   32 pps, indicating that loss of
PEX11  affects peroxisome abundance independently of
peroxisomal metabolism.
Discussion
PEX11 proteins were first identified as yeast PMPs that pro-
moted peroxisome division when overexpressed and caused a
significant reduction in peroxisome abundance when dis-
rupted (Erdmann and Blobel, 1995; Marshall et al., 1995;
Sakai et al., 1995). However, the mechanism by which
PEX11 proteins affect peroxisome division remains obscure.
A recent study by van Roermund et al. (2000) proposed that
PEX11 proteins act primarily in MCFA oxidation and affect
peroxisome division only indirectly through this role. This
hypothesis was consistent with much of the available data,
including the effect of PEX11 overexpression and underex-
pression on peroxisome abundance, the demonstration that
loss of PEX11 caused a significant reduction in MCFA oxi-
dation, and the observation that other defects in MCFA oxi-
Figure 5.  Loss of mouse PEX11  reduces peroxisome abundance 
in serum-free medium. (A) Peroxisome abundance in wild-type and 
PEX11 
 /  mouse fibroblasts. Solid bars represent peroxisome 
abundance in fibroblasts cultured in normal conditions, and open 
bars represent peroxisome abundance in fibroblasts cultured in 
serum-free medium for 24 h. (B–E) Representative wild-type (B and C) 
and PEX11 
 /  mouse fibroblasts (D and E) cultured in serum-free 
medium. Wild-type and PEX11 
 /  mouse were cultured 24 h in 
serum-free medium and then processed for indirect immunofluores-
cence with antibodies to the peroxisomal membrane protein PEX14 
(B and D) and matrix marker enzyme catalase (C and E). Samples 
were examined under a confocal fluorescence microscope and the 
number of peroxisomes present in 60 randomly selected cells was 
counted. Results in A are presented as the average peroxisome 
abundance   one standard deviation. Bar, 10  m.648 The Journal of Cell Biology | Volume 156, Number 4, 2002
dation also reduce peroxisome abundance in yeast cells.
However, some data are more difficult to reconcile with this
hypothesis. First, the defect in peroxisome abundance seen
in pex11 mutants was detected only during growth on oleic
acid, which is a long chain fatty acid, not an MCFA (van
Roermund et al., 2000). Second, PEX11 appears to act in
the transport of either MCFAs or ATP into the peroxisome
membrane (van Roermund et al., 2000), but lacks similarity
to known families of fatty acid transporters (Coe et al.,
1999; Hamilton, 1999; Stahl et al., 2001) and ATP trans-
porters (Saier, 2000; Palmieri et al., 2001; van Roermund et
al., 2001). Third, the yeast pex11 mutant also displays a de-
fect in the oxidation of long chain fatty acids (van Roer-
mund et al., 2000), which are imported and activated by
a different pathway than MCFAs (Hettema and Tabak,
2000). Fourth, mammalian peroxisomes do not oxidize
MCFAs (Wanders et al., 2001b), but do express PEX11 pro-
teins (Abe and Fujiki, 1998; Abe et al., 1998; Passreiter et
al., 1998; Schrader et al., 1998). These inconsistencies led us
to test the hypothesis of PEX11 function proposed by van
Roermund et al. (2000).
We first tested whether PEX11 overexpression was suffi-
cient to promote peroxisome division in the absence of any
peroxisome proliferating stimulus. Of more than 10 human
integral PMPs tested, only PEX11 overexpression was suffi-
cient to promote peroxisome division. We next tested
whether the peroxisome-proliferating effect of PEX11 
overexpression required metabolically active peroxisomes.
We observed that the peroxisome division-promoting effect
of PEX11  was the same or even greater in PEX5-deficient
PBD005 fibroblasts, which are unable to import peroxiso-
mal matrix enzymes and are defective in all peroxisomal
metabolic functions (Dodt et al., 1995). We also observed
that PEX11 overexpression in yeast was sufficient to pro-
mote peroxisome division. Our final test was to assess the ef-
fects of PEX11  deficiency on peroxisome division in fibro-
blasts grown in chemically defined, serum-free medium,
which lacks peroxisomal fatty acid oxidation substrates and
contains glucose and essential amino acids as the sole carbon
sources. We observed that PEX11 
 /  cells have only half
the peroxisome abundance of their WT counterparts. Taken
together, these results demonstrate that PEX11 proteins pro-
mote peroxisome division regardless of the metabolic state of
peroxisomes.
The simplest interpretation of these results is that PEX11
proteins play direct roles in promoting peroxisome division.
But what of the unquestionable requirement for yeast
PEX11 in MCFA oxidation? Does this reflect a direct or in-
direct role for PEX11 proteins in peroxisome metabolic
pathways? Although we cannot exclude a direct role for yeast
PEX11 in peroxisomal MCFA oxidation, it is curious that
the loss of yeast PEX11 also causes a significant reduction in
the peroxisomal oxidation of long chain fatty acids (van
Roermund et al., 2000), substrates that are thought to be
imported by a distinct pathway (Hettema and Tabak, 2000).
It is also notable that loss of mammalian PEX11  affects
both the peroxisomal fatty acid  -oxidation and peroxisomal
ether lipid synthesis pathways (unpublished data), two path-
ways that do not share even a single biochemical step (Wan-
ders et al., 2001a). In fact, current diagnostic procedures for
human peroxisomal diseases use a deficiency of both path-
ways as the means for differentiating between mere meta-
bolic defects and defects in peroxisome biogenesis (Wanders
et al., 2001a). One possible mechanism to explain the im-
pairment of multiple peroxisomal metabolic pathways in
pex11 mutant cells is that loss of PEX11 proteins may alter
the physical properties of the peroxisome membrane. If true,
this could impair metabolite transport across the peroxisome
membrane. It is also possible that such an alteration could
affect different transport systems to different degrees, ex-
plaining the near total defect in MCFA oxidation but only
partial defect in long chain fatty acid oxidation in yeast (van
Roermund et al., 2000), and the partial defects in fatty acid
 -oxidation and ether lipid synthesis in mammalian cells
(unpublished data). Our hypothesis of PEX11’s role in per-
oxisomal metabolism is also consistent with the fact that the
defect in MCFA oxidation can be overcome by permeabilizing
the peroxisome membrane (van Roermund et al., 2000) and
that PEX11 lacks structural similarities to known fatty acid
and nucleotide transporters (Coe et al., 1999; Saier, 2000).
Although the available evidence points to a direct role for
PEX11 proteins in peroxisome division, what is the nature
of this role? The strong correlation between PEX11 protein
levels and peroxisome abundance within the cell (Erdmann
and Blobel, 1995; Marshall et al., 1995; Sakai et al., 1995)
suggests that peroxisome division may be sensitive to PEX11
concentrations in the peroxisome membrane, although there
is also evidence that PEX11 activity may be affected by post-
translational modification (Marshall et al., 1996). Although
peroxisome division is a poorly understood process, Hoepf-
ner et al. (Hoepfner et al., 2001) have recently established
that the dynamin-related protein VPS1 is required for per-
oxisome division and that peroxisome motility requires the
class V myosin, MYO2. It will be interesting to determine
whether PEX11 proteins participate in VPS1-mediated per-
oxisome division or whether they act in some distinct pro-
cess, such as a coat-mediated peroxisome budding process
(Passreiter et al., 1998; Kirchhausen, 2000). In addition to
resolving these questions, future studies of peroxisome divi-
sion should explore the role of PEX11-interacting proteins
in the division process, as well as the possibility that PEX11
proteins may modify peroxisome lipids or recruit lipid-mod-
ifying activities to the peroxisome membranes.
One last point of discussion is the role of peroxisome me-
tabolism in regulating peroxisome abundance. The existence
of metabolic control over peroxisome abundance was estab-
lished by the observation that isolated defects in the hu-
man peroxisomal  -oxidation enzymes acyl-CoA oxidase or
2-enoyl-CoA hydratase/D-3-hydroxyacyl-CoA dehydroge-
nase bifunctional enzyme cause an 80% reduction in peroxi-
some abundance in human fibroblasts (Chang et al., 1999).
The van Roermund et al. (2000) report clearly extended this
observation to yeast, indicating that the phenomenon is evo-
lutionarily conserved. Like the mechanism of PEX11-medi-
ated peroxisome division, this phenomenon is poorly
understood. One attractive hypothesis is that metabolite flux
through peroxisomal  -oxidation pathways generates signal-
ing molecules that in turn regulate PEX11 activity. How-
ever, the levels of human PEX11  mRNA are not altered
in human cells that lack either acyl-CoA oxidase or thePEX11 promotes peroxisome division | Li and Gould 649
2-enoyl-CoA hydratase/D-3-hydroxyacyl-CoA dehydrogenase
binfunctional enzyme (Chang et al., 1999) and S. cerevisiae
PEX11 protein levels are not altered in peroxisomal fatty
acid oxidation mutants (van Roermund et al., 2000). Al-
though it is formally possible that PEX11 activity and fatty
acid oxidation might be linked by posttranslational mecha-
nisms, the sole report on posttranslational regulation of
PEX11 proposes that PEX11 activity should decrease with
increasing peroxisomal fatty acid oxidation activity (Mar-
shall et al., 1996). Thus, it may be that eukaryotic cells uti-
lize two mechanisms for controlling peroxisome division,
one that acts through PEX11 proteins, and another, PEX11-
independent mechanism that is sensitive to metabolic flux
through peroxisomal fatty acid  -oxidation pathways.
Materials and methods
Plasmids
The plasmids pcDNA3-PEX11 myc (Schrader et al., 1998) and pcDNA3-
PMP34myc (Sacksteder et al., 2000; Jones et al., 2001) have been de-
scribed. The plasmid pPGK1-GFP/PTS1 was created by cloning a 1.6-kb
Sal-BamHI fragment of the PGK1 promoter and the BamHI-XbaI fragment
of GFP/PTS1 (Kalish et al., 1996) between the SalI and XbaI sites of pRS316
(Sikorski and Hieter, 1989). The GAL1-regulated expression vectors
pRS425/GAL1-PEX11, pRS425/GAL1-PEX13, and pRS425/GAL1-YPR128C
were created by amplifying the PEX11 (5 -CCCGGATCCATCAATATG-
GTCTGTGATACAC-3  and 5 -CACCGCGGCCGCTGGTCGTCAGGTAT-
CACGAGCG-3 ),  PEX13 (5 -CCCGGATCCCCTGCGATGTCATCCACAG-
CAG-3  and 5 -CACCGCGGCCGCCACCGCAGGCCTTGGATATTGC-3 ),
and YPR128C (5 -CCCGGATCCTCATCAATGTTAACTCTAGAGTCTGC-3 
and 5 -CACCGCGGCCGCCCAAGTGGCTCTTCTATTTCCAAG-3 ) genes
by PCR and cloning each gene between the BamHI and NotI sites of
pRS425 (Baker-Brachmann et al., 1998), followed by inserting a 900-bp
SalI-BamHI fragment containing the GAL1 promoter upstream of the
PEX11, PEX13, and YPR128C genes.
Cell lines, transfection, microinjection, immunofluorescence, 
and antibodies
The wild-type human skin fibroblast GM5756 and the PEX5-deficient cell
line PBD005 (Dodt et al., 1995) were cultured under standard conditions
(Slawecki et al., 1995), as were fibroblasts derived from PEX11 
 /  and
PEX11 
 /  mouse embryos (unpublished data). All transfections were per-
formed by electroporation (Chang et al., 1997) and microinjections were
performed with DNA at a concentration of 0.1  g/ml in reverse PBS buffer
(4 mM NaHPO4, 1 mM KH2PO4, 140 mM KCl, pH 7.3) (South and Gould,
1999). For immunofluorescence, cells were fixed in 3% formaldehyde in
Dulbecco’s modified PBS (DPBS) (Life Technologies), pH 7.1, for 20 min,
and then permeabilized in 25  g/ml digitonin or 1% Triton X-100 in DPBS
for 5 min. Cells were then incubated with primary antibodies for 30 min,
washed extensively in DPBS, incubated with fluorescently labeled second-
ary antibodies for 10 min, washed extensively in DPBS, and mounted on
slides. Rabbit antibodies against PEX14 have been described (Sacksteder et
al., 2000). Monoclonal antibodies to the myc epitope were obtained from
the tissue culture supernatant of the hybridoma 1–9E10 (Evan et al., 1985).
Sheep anti–human catalase antibodies were obtained from The Binding
Site. Secondary antibodies specific for rabbit and mouse antibodies were
obtained from commercial sources.
Yeast strains and culture conditions
Yeast strains used in this study were based on S. cerevisiae strain BY4733
(MATa, his3 200, leu2 0, met15 0, trp1 63, ura3 0). The strain XLY1
was generated by one-step PCR-mediated disruption of the PEX11 gene in
BY4733 using kanMX4 as the selectable maker (Baker-Brachmann et al.,
1998), followed by transformation with the URA3-based replicating vector
pPGK1-GFP/PTS1. The XLY2 strain was generated from XLY1 by one-step
PCR-mediated disruption of the POX1 gene using HIS3 as the selectable
maker. Plasmid transformations were performed using the LiOAc proce-
dure (Guthrie and Fink, 1991). All strains were cultured in minimal S me-
dium (0.17% yeast nitrogen base without ammonium sulfate [Sigma-
Aldrich]; 0.5% ammonium sulfate) with glucose (2%), galactose (1%), or
oleic acid/Tween 40 (0.2%, 0.02%) as carbon source. Media were supple-
mented with amino acids, uracil, and adenine as required (Guthrie and
Fink, 1991).
Peroxisome abundance measurements
To determine peroxisome abundance in human and mouse fibroblasts,
cells were examined by confocal fluorescence microscopy and fluores-
cence images were captured under identical conditions using an Ultra-
VIEW confocal imaging system (Nikon). Images were then analyzed by IP-
Lab-spectrum software (Scanalytics) and peroxisomes were automatically
identified as segments comprised of pixels with limiting range of intensity.
Segments in each cell were automatically counted, the sum of which
equaled the pps for that cell. For human fibroblasts, at least 30 randomly
selected cells were examined for each sample. For the analysis of mouse
fibroblasts, cells were grown for 24 h in chemically defined, serum-free
medium lacking lipids (DME; GIBCO BRL), and supplemented with 0.25%
BSA, 6.25   10
 8 M transferrin, 8.3   10
 7 M insulin, 3   10
 8 M sele-
nium, 2   10
 8 M progesteron, and 10
 4 M putrescine (all from Sigma-
Aldrich) (Bottenstein et al., 1980), and peroxisome abundance in 60 ran-
domly selected cells was determined. To determine the peroxisome
abundance in yeast, yeast strains BY4733, XLY1, and XLY2 transformed
with either pRS425/GAL1, or its derivatives pRS524/GAL1-PEX11,
pRS425/GAL1-PEX13, or pRS425/GAL1-YPR128C were grown in glucose,
galactose, or oleic acid medium. Cells were washed with DPBS buffer
twice, fixed with 3% formaldehyde for 30 min, and then examined under
an Olympus fluorescence microscope. Peroxisome abundance was deter-
mined in 120 cells from each sample.
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